[18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The aim of the present study was to develop an experimental paradigm for the study of serotonergic neurotransmission in humans using positron emission tomography and the 5-HT 2A selective radioligand [18 F]altanserin. [18 F]altanserin studies were conducted in seven subjects using the bolus/infusion approach designed for attaining steady state in blood and brain 2 hours after the initial [18 F]altanserin administration. Three hours after commencement of radiotracer administration, 0.25 mg/kg of the selective serotonin reuptake inhibitor, citalopram (Lundbeck, Valby, Denmark), was administered to all subjects as a constant infusion for 20 minutes. To reduce 5-HT 1A–mediated autoinhibition of cortical 5-HT release, four of the seven subjects were pretreated with the partial 5-HT 1A agonist pindolol for 3 days at an increasing oral dose (25 mg on the day of scanning). In each subject, the baseline condition (120 to 180 minutes) was compared with the stimulated condition (195 to 300 minutes). Despite a pronounced increase in plasma prolactin and two subjects reporting hot flushes compatible with an 5-HT–induced adverse effect, cortical [18 F]altanserin binding was insensitive to the citalopram challenge, even after pindolol pretreatment. The biochemical and cellular events possibly affecting the unsuccessful translation of the citalopram/pindolol challenge into a change in 5-HT 2A receptor binding of [18 F]altanserin are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 1×
“The technique has proven valuable in the study of the dopaminergic neurotransmission in schizophrenia (Breier et al., 1997; Laruelle et al., 1996) with possible implications for the understanding of the pathophysiology of the disease and the development of new treatment strategies (Carlsson et al.,…”
MethodBreier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 1×
“The technique has proven valuable in the study of the dopaminergic neurotransmission in schizophrenia (Breier et al., 1997; Laruelle et al., 1996) with possible implications for the understanding of the pathophysiology of the disease and the development of new treatment strategies (Carlsson et al.,…”
MethodImaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors
Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90327-7 · Cited by 355 · cited 2×
“Because the cerebellar 5-HT2A receptor density is very small (Pazos et al., 1987; Schotte et al., 1983), and because PET studies with blocking doses of ketanserin failed to show any displacing effect on cerebellar [18F]altanserin binding (Pinborg et al., 2003), the difference in cerebellar…”
BackgroundNeurotransmitter interactions in schizophrenia–therapeutic implications
Carlsson, A., Waters, N., & Carlsson, M. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00117-1 · Cited by 298 · cited 1×
“…has proven valuable in the study of the dopaminergic neurotransmission in schizophrenia (Breier et al., 1997; Laruelle et al., 1996) with possible implications for the understanding of the pathophysiology of the disease and the development of new treatment strategies (Carlsson et al., 1999).”
BackgroundSun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99
Fujita, M., Al‐Tikriti, M. S., Tamagnan, G., Zoghbi, S. S., Bozkurt, A., Baldwin, R. M., & Innis, R. B. (2003) · Synapse · doi:10.1002/syn.10194 · Cited by 24 · cited 1×
“…change in radioligand binding after pharmacologic challenge for the D1 receptor system (Abi-Dargham et al., 1999; Chou et al., 1999), the 5-HT1A receptor system (Abi-Dargham et al., 1997; Hume et al., 2001; Maeda et al., 2001), and the nicotinic acetylcholine receptor system (Fujita et al., 2003).”
Background
Cited by
Finnema, S. J., Stepanov, V., Ettrup, A., Nakao, R., Amini, N., Svedberg, M., Lehmann, C., Hansen, M., Knudsen, G. M., & Halldin, C. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.035 · Cited by 72
Self-citationRadiosynthesis and Evaluation of 11C-CIMBI-5 as a 5-HT2A Receptor Agonist Radioligand for PET
Ettrup, A., Palner, M., Gillings, N., Santini, M. A., Hansen, M., Kornum, B. R., Rasmussen, L. K., Någren, K., Madsen, J., Begtrup, M., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.074021 · Cited by 50
Self-citationJørgensen, L. M., Weikop, P., Villadsen, J., Visnapuu, T., Ettrup, A., Hansen, H. D., Baandrup, A. O., Andersen, F. L., Bjarkam, C. R., Thomsen, C., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16629483 · Cited by 44
“In a previous PET study in humans using the 5HT2A receptor antagonist [ (18)F]altanserin, intervention with citalopram þ pindolol did not change the occupancy.(8) This difference could, however, also be ascribed to a higher sensitivity to 5-HT competition with the 5HT2A receptor agonist [ (11)C]Cimbi36 compared to the…”
BackgroundSelf-citation
Metadata
- Authors
- Pinborg, L. H., Adams, K. H., Yndgaard, S., Hasselbalch, S. G., Holm, S., Kristiansen, H., Paulson, O. B., & Knudsen, G. M.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2004-09
- Volume
- 24
- Issue
- 9
- Pages
- 1037-1045
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W1967881177
- Cited by
- 46
- References
- 9
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge. https://app.cochat.ai/papers/10.1097/01.wcb.0000126233.08565.e7
- The paper
- Pinborg, L. H., Adams, K. H., Yndgaard, S., Hasselbalch, S. G., Holm, S., Kristiansen, H., Paulson, O. B., & Knudsen, G. M. (2004). [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1097/01.wcb.0000126233.08565.e7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.